The aim of this project is to examine the fetal adverse outcomes in pregnancies treated with both antidiabetics and antidepressants. We will study data from both national and local databases in combination with new biological data. Our results will contribute with knowledge on these potentially high-risk pregnancies and improve the opportunities for counselling of targeted treatment of depression in pregnant women with co-existing diabetes.